ADVFN US – Market Content Editor
-
Sally Beauty shares rise after Q3 profit beats estimates, margin guidance lifted
Sally Beauty Holdings Inc (NYSE:SBH) reported third-quarter earnings on Tuesday that surpassed analyst expectations, driven by margin improvements fueled by cost-cutting efforts despite a slight dip in sales. The professional hair color retailer posted adjusted earnings of $0.51 per share for the quarter ended June 30, well above the $0.43 consensus. Revenue totaled $933 million,…
-
Zebra Technologies shares surge after Q2 earnings beat, raises full-year forecast
Zebra Technologies Corporation (NASDAQ:ZBRA) reported second-quarter earnings on Tuesday that outperformed analyst expectations, leading to a notable jump in its shares and an upgraded full-year outlook, alongside announcing a major acquisition. Shares climbed 8.71% in pre-market trading following the news. The company, specializing in digitizing and workflow automation, posted adjusted earnings per share of $3.61…
-
Pfizer lifts 2025 profit forecast after strong Q2 beats, shares rise
Pfizer (NYSE:PFE) raised its full-year earnings outlook on Tuesday after reporting second-quarter results that surpassed Wall Street expectations, driving its shares up more than 3% in premarket trading. The pharmaceutical giant posted earnings per share of $0.78 for Q2, comfortably ahead of the $0.57 consensus forecast. Revenue climbed 10% year-over-year to $14.7 billion, also exceeding…
-
Marathon Petroleum tops Q2 forecasts on strong refining performance
Marathon Petroleum Corp. (NYSE:MPC) posted better-than-expected second-quarter earnings on Tuesday, driven by robust execution in its refining and commercial operations, despite headwinds in refining margins. Following the report, shares of the energy giant dipped slightly by 0.10% in after-hours trading. The company reported net income of $1.2 billion, or $3.96 per diluted share, handily beating…
-
Caterpillar shares slide as tariffs pressure Q2 earnings despite revenue beat
Caterpillar Inc. (NYSE:CAT) saw its stock fall 2.3% on Tuesday after the company reported second-quarter 2025 earnings that came in below analyst expectations, as increased manufacturing costs tied to tariffs weighed on profitability. This came despite stronger-than-expected revenue figures. The company posted adjusted earnings of $4.72 per share for the quarter, missing the analyst consensus…
-
Eaton stock slides 6% despite record Q2 results as Q3 outlook disappoints
Shares of Eaton Corporation plc (NYSE:ETN) dropped 6.4% on Tuesday, as investors reacted negatively to the company’s third-quarter earnings forecast, even as the power management firm posted record second-quarter results that beat expectations. Eaton reported adjusted earnings per share of $2.95 for Q2, narrowly surpassing the analyst estimate of $2.93. Revenue hit an all-time quarterly…
-
Clear Channel Outdoor stock jumps over 4% as Q2 results beat expectations and outlook improves
Clear Channel Outdoor Holdings, Inc. (NYSE:CCO) saw its stock rise 4.55% in after-hours trading on Tuesday after the company posted second-quarter revenue that surpassed forecasts, driven by robust growth in its Airports segment and ongoing advances in digital advertising. The out-of-home advertising firm reported Q2 revenue of $402.81 million, topping analyst expectations of $397.37 million.…
-
Diageo shares rise on stronger-than-expected FY25 results and solid guidance
Shares of Diageo (NYSE:DEO) climbed nearly 3% in London on Tuesday after the global spirits giant delivered better-than-anticipated results for its fiscal year ending June 2025, coupled with a confident outlook for operating profit growth. The company reported net sales of $20.25 billion, essentially flat on a reported basis but up 1.7% organically. Both figures…
-
Agilon Health shares plunge after Q2 miss, leadership shakeup, and suspended guidance
Agilon Health Inc. (NYSE:AGL) saw its stock plummet over 25% in pre-market trading Tuesday after reporting second-quarter results that missed expectations and withdrawing its full-year guidance amid executive turnover and mounting industry pressures. The healthcare provider reported a quarterly net loss of $0.25 per share, more than double the analyst consensus estimate of $0.11. Revenue…
-
Amneal Pharmaceuticals lifts annual outlook after strong Q2, Specialty segment drives growth
Amneal Pharmaceuticals (NASDAQ:AMRX) reported better-than-expected second-quarter results on Tuesday, as strength in its Specialty division helped lift earnings, prompting the company to raise its full-year profit guidance. The company’s stock rose 1.13% in after-hours trading following the release. Adjusted earnings for the quarter came in at $0.25 per share, beating the $0.17 analyst consensus and…